DDIT3 and diffuse large B-cell lymphoma: However, lenalidomide combined with R-CHOP did not significantly prolong PFS versus R-CHOP alone (hazard ratio, 0.85; 95% confidence interval [CI], 0.63–1.14; p = 0.29) in first-line ABC DLBCL [24].